Rafael Holdings Inc Class B is a real estate services business based in the US. Rafael Holdings Inc Class B shares (RFL) are listed on the NYSE and all prices are listed in US Dollars. Rafael Holdings Inc Class B employs 51 staff and has a trailing 12-month revenue of around $4 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $1.80 |
|---|---|
| 52-week range | $1.60 - $37.09 |
| 50-day moving average | $2.18 |
| 200-day moving average | $2.80 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-6.97 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.8 from 2022-09-29
| 1 week (2022-09-23) | -7.69% |
|---|---|
| 1 month (2022-08-30) | -17.81% |
| 3 months (2022-06-30) | -3.74% |
| 6 months (2022-03-28) | -28.57% |
| 1 year (2021-09-30) | -94.14% |
|---|---|
| 2 years (2020-09-30) | -88.39% |
| 3 years (2019-09-30) | 20.96 |
| 5 years (2017-09-26) | N/A |
| Revenue TTM | $4 million |
|---|---|
| Gross profit TTM | $4 million |
| Return on assets TTM | -16.41% |
| Return on equity TTM | -127.01% |
| Profit margin | 0% |
| Book value | $4.73 |
| Market capitalisation | $46.9 million |
TTM: trailing 12 months
We're not expecting Rafael Holdings Inc Class B to pay a dividend over the next 12 months.
Over the last 12 months, Rafael Holdings Inc Class B's shares have ranged in value from as little as $1.6 up to $37.09. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Rafael Holdings Inc Class B's is 1.7891. This would suggest that Rafael Holdings Inc Class B's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.